Evidence map›Paper›PMID 40587044›Full record

ArticleJournal of fluorescence2025

Design, Synthesis, Antimicrobial Evaluation, Molecular Docking, and Computational Studies of New 1,2,4-Triazolo[4,3-a]pyrimidin-5(1 H)-one Derivatives.

Abd-Allah S El-Etrawy, Noha Ryad, Amr Fouda, Farag F Sherbiny, Adel A H Abdel-Rahman, Mahmoud A S Sakr

Abstract read
In one paragraph

Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abd-Allah S El-EtrawyDepartment of Chemistry, Center of Basic Science (CBS), Misr University for Science and Technology (MUST), Al-Motamayez District, 6th of the October City 77, Giza, Egypt.
Noha RyadPharmaceutical Organic Chemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), 6th of October City, P.O. Box 77, Giza, Egypt.
Amr FoudaBotany and Microbiology Department, Faculty of Science, Al-Azhar University, Nasr City, Cairo, 11884, Egypt.
Farag F SherbinyPharmaceutical Organic Chemistry Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt.
Adel A H Abdel-RahmanDepartment of Chemistry, Faculty of Science, Menoufia University, Shebin El-Koam, Egypt.
Mahmoud A S SakrDepartment of Chemistry, Center of Basic Science (CBS), Misr University for Science and Technology (MUST), Al-Motamayez District, 6th of the October City 77, Giza, Egypt. mahmoud.sakr@must.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study reports the synthesis and comprehensive characterization of a new series of 1,2,4-triazolo[4,3-a] pyrimidin-5-(1H)-one derivatives. These compounds were synthesized from 2-hydrazinopyrimidines via cyclization reactions. Density Functional Theory (DFT) calculations revealed the molecular structures, stability, and electronic properties of the derivatives. Computational studies revealed that the compounds exhibited planar conformations, though the triazole rings were found to be non-coplanar with the pyrimidine ring. Substituents like methyl, amino, and propyl groups influenced bond lengths, dihedral angles, and electronic properties. Binding energies confirmed molecular stability, while IR spectra supported dynamical stability. UV-Vis’s absorption spectra matched experimental data, showing maxima in the 250–400 nm range, with redshifts attributed to electron-donating substituents. Density of State (DOS) and HOMO/LUMO analyses indicated strong orbital interactions and electron delocalization. Molecular docking studies suggested favorable binding with the DNA gyrase receptor, indicating potential antimicrobial activity against both Gram-positive and Gram-negative bacteria. This study provides valuable insights into the synthesis, structural, electronic, and antimicrobial properties of 1,2,4-triazolo[4,3-a] pyrimidin-5-(1H)-one derivatives, highlighting their potential applications in medicinal chemistry and materials science.

Indexed as

Anti-Infective AgentsPyrimidinonesTriazolesDensity Functional TheoryDrug DesignMicrobial Sensitivity TestsMolecular Docking SimulationStructure-Activity RelationshipAnti-Infective AgentsPyrimidinonesTriazoles[1,2,4] triazolo[4,3-a] PyrimidineAntimicrobial activityDFTDNA gyrase BMolecular dockingTD-DFT

Identifiers

PMID40587044
PMCPMC12718226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.